Imaging and therapy with radionuclide labeled magnetic nanoparticles

Brazilian Archives of Biology and Technology

Volumn 51, Issue SPECIALISSUE, 2008, Pages 31-37

  Ünak, Perihan ^a  

^a EGE UNIVERSITY   (Turkey)

Author keywords

Imaging; Iron oxide; Magnetite nanoparticles; Radionuclide; Targeted drug delivery; Therapy

Indexed keywords

EID: 84862682004     PISSN: 15168913     EISSN: 16784324     Source Type: Journal    
DOI: 10.1590/S1516-89132008000700006     Document Type: Article

References (36)

1. Ahlberg, A.; Mikulowski, P.; Odelberg-Johnson, O. (1969), Intra-articular injection of radioactive gold in treatment of chronic synovial effusion in the knee. Acta Rheumatol Scand., 15, 81-89.
2. Bekis, R.; Medine, I.; Dagdeviren, K.; Ünak, P. (2008), A new method for sentinel lenf detection. Turkish J Nucl Med., 17, 49.
3. Bjerner, T.; Wikstrom, G.; Johansson, L.; Ahlström H. (2004), High in-Plane Resolution T2-Weighted Magnetic Resonance Imaging of Acute Myocardial Ischemia in Pigs Using The Intravascular Contrast Agent NC100150 Injection. Invest Radiol., 39, 470- 478.
4. Campo, A. D.; Sena T.; Lellouche, J. P.; Bruce, I. J. (2005), Multifunctional magnetite and silicamagnetite nanoparticles: Synthesis,surface activation and applications in life sciences. J Magn Magn Mater., 293, 33-40.
5. Dagdeviren, K.; Ünak, P.; Bekis, R.; Biber, Z.; Akdurak, S.; Ulker, O.; Ergur, B.; Ertay, T.; Durak, H. (2007), Radioiodinated magnetic targeted carriers (I-131-MTC). J Radioanal Nucl Chem., 273, 635- 639.
6. Daldrup, H. E.; Link, T.M.; Blasius, S; Kšnemann, S.; Jÿrgens, H.; Rummeny, E. J. (1999), Monitoring Radiation-Induced Changes in Bone Marrow Histopathology with Ultra-Small Superparamagnetic Iron Oxide (USPIO)-Enhanced MRI. J Magn Resonance, 9, 643-652.
7. Dobson, J. (2006), Magnetic micro- and nano-particlebased targeting for drug and gene delivery. Nanomedicine, 1, 31-37.
8. Fortina, P.; Kricka, L. J.; Graves, D. J.; Park, J.; Hyslop, T.; Tam, F.; Halas, N.; Surrey, S.; Waldman, S. A. (2007), Applications of nanoparticles to diagnostics and therapeutics in colorectal cancer. Opin Trends Biotechnol., 25, 145-153.
9. Fuente, J. M.; Alcantara, D.; Eaton, P.; Crespo, P.; Rojas, T. C.; Fernandez, A.; Hernando, A.; Penades, S.; (2006), Gold and Gold-Iron Oxide Magnetic Glyconanoparticles: Synthesis, Characterization and Magnetic Properties, J Phys Chem. B, 110, 13021- 13028.
10. Gaihre, B.; Aryal, S.; Khil, M. S.; Kim, H. Y. (2008), Encapsulation of Fe3O4 in gelatin nanoparticles: Effect of different parameters on size and stability of the colloidal dispersion. J Microencapsul., 25, 21-30.
11. Gupta, A. K.; Gupta, M. (2005), Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials, 26, 3995- 4021.
12. Heckl, S. (2007), Future contrast agents for molecular imaging in stroke. Curr Med Chem., 14, 1713-1728.
13. Jeong, J. M.; Chung, K. K. (2003), Therapy with Re- 188-labeled radiopharmaceuticals: an overview of promising results from initial clinical trials. Cancer Biother Radiopharm., 18, 707-717.
14. Johnson, A. K.; Zawadzka, A. M.; Deobald, L. A.; Crawford, R. L., Paszczynski, A. J. (2008), Novel method for immobilization of enzymes to magnetic nanoparticles. J Nanopart Res., 10, 1009-1025.
15. Jung, C. (1995), Surface properties of superparamagnetic iron oxide MR contrast agents: Ferumoxides, ferumoxtran, ferumoxsil. Magn Reson Imaging, 13, 675-691.
16. Kreuter, J. (2007), Nanoparticles a historical perspective. Inter J Pharm., 331, 1-10.
17. Lankester, K. J., Maxwell, R. J., Pedley, R. B., Dearling, J. L.; Qureshi, U. A.; El-Emir, E.; Hill, S. A.; Tozer, G. M. (2007), Combretastatin A-4- phosphate effectively increases tumor retention of the therapeutic antibody, I-131-A5B7, even at doses that are sub-optimal for vascular shut-down. Int J Oncol., 30, 453-460.
18. Maria, G. C.; Claudia, C.; Zhouhai, Z. (2002), Gelatin nanoparticles produced by a simple W/O emulsion as delivery system for methotreaxate. J Mater Sci Mater Med., 13, 523-526.
19. Moses, C.; Kent, E.; Boatman, J. B.; Cole, R. D.; Sunder, J. H.; George, R. S.; Russ, C.; Ford, W. B.; Kutz, E. R. (1955), Experimental and clinical studies with radioactive colloidal gold in the therapy of serous effusions arising from cancer. Cancer, 8, 417- 423.
20. Muniyandy, S., Bhaskar, K., Maharajan, G., Pillar, K. S. (2004), Ultrasonically controlled release and targeted delivery of diclofenac sodium via gelatin magnetic microspheres. Int J Pharm., 283, 71-82.
21. Neouze, M. A.; Schubert, U.; (2008), Surface modification and functionalization of metal and metal oxide nanoparticles by organic ligands, Monatshefte Fur Chemie, 139, 183-195.
22. Neves, M.; Reis, F.; Waerenborgh, F.; Martinho, E.; Patricio, L. (1987a), 166Holmium: a potential lanthanide element in radiotherapy. Inorg Chim Acta, 140, 359-360.
23. Neves, M.; Waerenborgh, F.; Patricio, L. (1987b), 109Palladium and 166Holmium potential radionuclides for synoviotherapy-radiation absorbed dose calculations. Appl Radiat Isot., 38, 745-749.
24. Pintaske, J.; Bantleon, R.; Kehlbach, R.; Claussen, C. D.; Wiskirchen, J.; Schick, F. (2006), Effect of concentration of SHU 555A labeled human melanoma cells on MR spin echo and gradient echo signal decay at 0.2, 1.5, and 3T. MAGMA., 19, 71-77.
25. Saravanan, M.; Bhaskar, K.; Narayanan, V. S. N.; Maharajan, G.; Pillai, K. S. (2003), Diclofenace sodium loaded gelatin magnetic microspheres for intra-arterial administration: Formulation, characterization and in vitro release studies. Boll Chim Farm., 142, 347-351.
26. Shabat, S.; Kollender, Y.; Merimsky, O.; Isakov, J.; Flusser, G.; Nyska, M.; Meller, I. (2002), The use of surgery and Yttrium 90 in the management of extensive and diffuse pigmented villonodular synovitis of large. Rheumatology, 41, 1113-1118.
27. Sonvico, F.; Mornet, S.; Vasseur, S.; Dubernet, C.; Jaillard, D.; Degrouard, J.; Hoebeke, J.; Duguet, E.; Colombo, P.; Couvreur, P. (2005) Folate-conjugated iron oxide nanoparticles for solid tumor targeting as potential specific magnetic hyperthermia mediators: synthesis, physicochemical characterization, and in vitro experiments. Bioconjugate Chem., 16, 1181- 1187.
28. Stevens, N.; O'Connor, N.; Vishwasrao, H.; Samaroo, D.; Kandel, E. R.; Akins, D. L.; Drain, C. M.;Turro, N. J. (2008), Two Color RNA Intercalating Probe For Cell Imaging Applications. J Am Chem Soc., 130, 71-82.
29. Sun, C.; Lee, J. S. H.; Zhang, M. (2008), Magnetic nanoparticles in MR imaging and drug delivery. Adv Drug Deliv Rev., 60, 1252-1265.
30. Sun, H.; Yua, J.; Gonga,, P.; Xua, D.; Zhanga, C.; Yao, S. (2005), Novel core-shell magnetic nanogels synthesized in an emulsion-free aqueous system under UV irradiation for targeted radiopharmaceutical applications. J Magn Magn Mater., 294, 273-280.
31. Thunemann, A. F.; Schutt, D.; Pison, U.; Mohwald, H. (2006), Maghemite Nanoparticles Protectively Coated with Poly(ethylene imine) and Poly(ethylene oxide)-block-poly(glutamic acid), Langmuir, 22, 2351-2357.
32. Ünak, P.; Medine, E. D. (2007), Tc-99m Labeled Magnetite Nanoparticles As Drug Carriers, EANM'07 - Annual Congress of the European Association of Nuclear Medicine. Eur J Nucl Med Mol Imaging, 34, 133.
33. Ünak, P.; Medine, E. I.; Sakarya, S.; Yürekli, Y. (2008), Synthesis of radionuclide labeled magnetic nanoparticules and investigation of their therapeutic potentials in cells. TUBITAK research project report no SBAG 3293 (105S486), 135 p.
34. Vassallo, P.; Matei, C.; Heston, W. D.; McLachlan, S. J.; Koutcher, J. A.; Castellino, R. A. (1994), AMI- 221-enhanced MR lymphography -usefulness for differentiating reactive from tumor-bearing lymphnodes. Radiology, 193, 501-506.
35. Volkert, W. A.; Hoffman, T. J. (1999), Therapeutic radiopharmaceuticals. Chem. Rev., 9, 2269-2292.
36. Wessels, B. W.; Mears, C. F. (2000), Physical and chemical properties of radionuclide therapy. Semin Radiat Oncol., 10, 115-122.